Compare The Vita Coco Company Inc (COCO) vs Rocket Lab USA Inc (RKLB) Price & Performance

The Vita Coco Company (COCO) trades at $62.25, down 2.92% over 24 hours, with a bullish technical signal driven by oversold RSI readings and support near $62. Fundamentally, Q2 2026 earnings beat expectations with EPS of $0.82 versus $0.56 estimated, while revenue grew 28% year-over-year to $216 million. The company raised full-year 2026 guidance, reflecting strong demand and the Copra acquisition.

Outlook remains positive with 60% analyst buy ratings and an $80.67 consensus price target, implying ~30% upside. Key risks include margin pressure from rising costs and capacity constraints. Growth catalysts include international expansion and health-focused innovation in the beverage sector.

Rocket Lab (RKLB) trades at $82.83, up 9.46% today, reflecting strong momentum despite recent volatility. The stock shows a bullish technical setup with key resistance at $85 and support at $79, while fundamentals reveal rapid revenue growth—Q2 2026 revenue surged 62% to $234.1 million—but persistent losses, with a net income margin of -26.87%. Analyst sentiment is overwhelmingly positive, with 76% buy ratings and a $115.11 consensus target, though cash burn and Neutron rocket costs pose execution risks.

The outlook hinges on scaling launch services and space systems to achieve profitability, backed by a record $2.36 billion backlog. Near-term catalysts include Q3 earnings and European expansion, but investors face risks from high valuations (P/S of 60.8) and competitive pressure from SpaceX. Upside potential exists if margin improvements materialize, but the stock remains speculative given its loss-making profile.